Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
907
datasets available to search
ShareScore release 0.7.1
Dataset results
907 results for “HCV”
Efficacy and Safety of Sofosbuvir/Velpatasvir Fixed Dose Combination for 12 Weeks in Adults With Chronic Hepatitis C Virus (HCV) and Human Immunodeficiency Virus (HIV)-1 Coinfection
ClinicalTrials.gov study NCT02480712. IPD Sharing: YES. Countries: 1. Publications: 1.
Safety and Efficacy of Ledipasvir/Sofosbuvir (LDV/SOF) Fixed Dose Combination Tablet With Ribavirin for 12 Weeks in Treatment-naive Adults With Chronic HCV Genotype 3 Infection
ClinicalTrials.gov study NCT02413593. IPD Sharing: YES. Countries: 1. Publications: 1.
Safety and Efficacy of Sofosbuvir/Velpatasvir/Voxilaprevir Fixed-Dose Combination With or Without Ribavirin in Participants With Chronic Genotype 1 HCV Infection Previously Treated With a Direct Actin
ClinicalTrials.gov study NCT02536313. IPD Sharing: YES. Countries: 1. Publications: 1.
Pegylated Interferon Alfa-2a Maintenance Therapy and Liver Disease Progression in People Infected With Both HIV and Hepatitis C Virus (HCV)
ClinicalTrials.gov study NCT00078403. IPD Sharing: Not stated. Countries: 2. Publications: 12.
Efficacy and Safety of Sofosbuvir Plus Ribavirin in Adults With Chronic HCV Infection
ClinicalTrials.gov study NCT02021643. IPD Sharing: Not stated. Countries: 5. Publications: 3.
Safety and Efficacy of SOF/VEL/VOX FDC for 8 Weeks and SOF/VEL for 12 Weeks in Adults Chronic Genotype 3 HCV Infection and Cirrhosis
ClinicalTrials.gov study NCT02639338. IPD Sharing: YES. Countries: 8. Publications: 1.
Universal HIV Screening and Targeted HCV Screening in Emergency Department
ClinicalTrials.gov study NCT03595527. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Safety and Tolerability Study of Nitazoxanide in HIV-HCV Treatment Failures
ClinicalTrials.gov study NCT01185028. IPD Sharing: Not stated. Countries: 1. Publications: 3.
Ledipasvir/Sofosbuvir in Adults With Chronic Hepatitis C Virus (HCV) Infection Who Are on Dialysis for End Stage Renal Disease
ClinicalTrials.gov study NCT03036839. IPD Sharing: YES. Countries: 5. Publications: 1.
Safety and Efficacy of Ledipasvir/Sofosbuvir in Adults With Chronic HCV Infection
ClinicalTrials.gov study NCT02472886. IPD Sharing: YES. Countries: 2. Publications: 1.
Evaluate the Efficacy and Safety of Sofosbuvir/Velpatasvir Fixed-Dose Combination and Ribavirin for 12 Weeks in Participants With Chronic HCV Infection and Child-Pugh-Turcotte Class C Cirrhosis
ClinicalTrials.gov study NCT02994056. IPD Sharing: YES. Countries: 2. Publications: 0.
Multi-Center, Randomized, Open-Label Study of G/P +/- RBV for NS5A + SOF Previously Treated GT1 HCV Subjects
ClinicalTrials.gov study NCT03092375. IPD Sharing: NO. Countries: 1. Publications: 2.
A Direct obserVed therApy vs fortNightly CollEction Study for HCV Treatment - ADVANCE HCV Study
ClinicalTrials.gov study NCT03236506. IPD Sharing: NO. Countries: 1. Publications: 2.
Efficacy and Safety of 8-weeks of Glecaprevir/Pibrentasvir in Treatment-Naïve Adults With HCV Genotype 1-6 and Aspartate Aminotransferase to Platelet Ratio Index (APRI) ≤1
ClinicalTrials.gov study NCT03212521. IPD Sharing: YES. Countries: 10. Publications: 1.
Low-Dose Peginterferon and Ribavirin to Treat Chronic Hepatitis C in Patients Infected With HCV Genotype 2 or 3
ClinicalTrials.gov study NCT00056862. IPD Sharing: Not stated. Countries: 1. Publications: 4.
PROPHESYS 1: An Observational Study on Predictors of Response in Treatment-naïve Patients With Chronic Hepatitis C Virus (HCV)Treated With Pegasys (Peginterferon Alfa-2a)
ClinicalTrials.gov study NCT01070550. IPD Sharing: Not stated. Countries: 14. Publications: 2.
4 Week Combination of BI 207127 NA With Peg-IFN and Ribavirin in Chronic HCV Patients
ClinicalTrials.gov study NCT00905632. IPD Sharing: Not stated. Countries: 3. Publications: 1.
Study of Sirolimus Versus Mycophenolate Liver Transplant Recipients With Recurrent Hepatitis C Virus (HCV)
ClinicalTrials.gov study NCT01134952. IPD Sharing: Not stated. Countries: 1. Publications: 14.
Safety and Efficacy of Ledipasvir/Sofosbuvir (LDV/SOF) Fixed Dose Combination (FDC) for 12 or 24 Weeks in Kidney Transplant Recipients With Chronic HCV Infection
ClinicalTrials.gov study NCT02251717. IPD Sharing: YES. Countries: 4. Publications: 1.
Quality of Life Measurement in Treatment Naïve Patients With Hepatitis C Virus (HCV) Genotype 1 (GT1) Suffering From Fatigue and Receiving Ombitasvir, Paritaprevir, and Ritonavir and Dasabuvir (Viekir
ClinicalTrials.gov study NCT03002818. IPD Sharing: UNDECIDED. Countries: 1. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.